Clinical trial
Photodynamic Therapy in Treating Patients With Skin Cancer
NCT00002975 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00002975 |
|---|---|
| Title | Photodynamic Therapy in Treating Patients With Skin Cancer |
| Official title | A Phase II Trial of 4-5 Hour and 18-24 Hour Applications of 20% Topical ALA for Photodynamic Therapy of Cutaneous Carcinomas and Actinic Keratoses |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-melanomatous Skin Cancer, Precancerous Condition |
| Intervention type | Drug |
| Interventions | aminolevulinic acid |
| Enrollment | 180 |
| Start date | Feb 1, 1997 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: